Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Kittikhun Wangkanont, et al.
Asian Pacific Journal of Allergy and Immunology (2020)
Open Access | Times Cited: 482

Showing 26-50 of 482 citing articles:

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, et al.
Annals of Clinical Microbiology and Antimicrobials (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 134
Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
Kaewta Rattanapisit, Balamurugan Shanmugaraj, Suwimon Manopwisedjaroen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 134
The possible of immunotherapy for COVID-19: A systematic review
Akram AminJafari, Sorayya Ghasemi
International Immunopharmacology (2020) Vol. 83, pp. 106455-106455
Open Access | Times Cited: 133
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
Ranjan K. Mohapatra, Lucia Pintilie, Venkataramana Kandi, et al.
Chemical Biology & Drug Design (2020) Vol. 96, Iss. 5, pp. 1187-1208
Open Access | Times Cited: 127
Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
Hua Li, Zhe Liu, Junbo Ge
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 12, pp. 6558-6570
Open Access | Times Cited: 111
Drug Discovery Strategies for SARS-CoV-2
Zeenat A. Shyr, Kirill Gorshkov, Catherine Z. Chen, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 375, Iss. 1, pp. 127-138
Open Access | Times Cited: 105
Micronutrients as immunomodulatory tools for COVID-19 management
Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, et al.
Clinical Immunology (2020) Vol. 220, pp. 108545-108545
Open Access | Times Cited: 102
Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
Begum Dariya, Ganji Purnachandra Nagaraju
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 43-52
Open Access | Times Cited: 101
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
Igor Andrade Santos, Victória Riquena Grosche, Fernando R.G. Bergamini, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 100
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
Vicky Yamamoto, Joe F. Bolanos, John Fiallos, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 2, pp. 459-504
Open Access | Times Cited: 96
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
Umesh Kalathiya, Monikaben Padariya, Marcos Yébenes Mayordomo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1473-1473
Open Access | Times Cited: 95
Probiotics: A potential immunomodulator in COVID-19 infection management
Kuljit Singh, Alka Rao
Nutrition Research (2021) Vol. 87, pp. 1-12
Open Access | Times Cited: 95
Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options
Jesada Kanjanaumporn, Songklot Aeumjaturapat, Kornkiat Snidvongs, et al.
Asian Pacific Journal of Allergy and Immunology (2020)
Open Access | Times Cited: 91
The current understanding and potential therapeutic options to combat COVID-19
Venkatesh Pooladanda, Sowjanya Thatikonda, Chandraiah Godugu
Life Sciences (2020) Vol. 254, pp. 117765-117765
Open Access | Times Cited: 89
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
Abdolreza Esmaeilzadeh, Reza Elahi
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2519-2543
Open Access | Times Cited: 89
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107364-107364
Open Access | Times Cited: 88
Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission
Daniella S. Battagello, Guilherme Dragunas, Marianne Klein, et al.
Clinical Science (2020) Vol. 134, Iss. 16, pp. 2137-2160
Open Access | Times Cited: 86
Targeting Lipid Rafts as a Strategy Against Coronavirus
Maurizio Sorice, Roberta Misasi, Gloria Riitano, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 82
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises
Arefeh Basiri, Zahra Pazhouhnia, Nima Beheshtizadeh, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 163-175
Open Access | Times Cited: 79
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
Khan Sharun, Ruchi Tiwari, Mohd. Iqbal Yatoo, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 9, pp. 1033-1046
Closed Access | Times Cited: 79
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
Arif Hussain, Anwarul Hasan, Mohammad Mahdi Nejadi Babadaei, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110559-110559
Open Access | Times Cited: 76
Immunotherapeutic approaches to curtail COVID-19
Hajar Owji, Manica Negahdaripour, Nasim Hajighahramani
International Immunopharmacology (2020) Vol. 88, pp. 106924-106924
Open Access | Times Cited: 75
Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
Sourena Sharifkashani, Melika Arab Bafrani, Alireza Soltani Khaboushan, et al.
European Journal of Pharmacology (2020) Vol. 884, pp. 173455-173455
Open Access | Times Cited: 74
Tackling SARS-CoV-2: Proposed Targets and Repurposed Drugs
Siddhi Joshi, Maithili Joshi, Mariam S. Degani
Future Medicinal Chemistry (2020) Vol. 12, Iss. 17, pp. 1579-1601
Open Access | Times Cited: 73
Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors
Mujahed I. Mustafa, Abdelrahman H. Abdelmoneim, Eiman M. Mahmoud, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-7
Open Access | Times Cited: 71

Scroll to top